These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32184858)

  • 1.
    Babaei Khorzoughi R; Namvarjah F; Teimouri M; Hosseini H; Meshkani R
    Iran J Pharm Res; 2019; 18(4):1921-1930. PubMed ID: 32184858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chlorogenic acid improves anti-lipogenic activity of metformin by positive regulating of AMPK signaling in HepG2 cells.
    Namvarjah F; Shokri-Afra H; Moradi-Sardareh H; Khorzoughi RB; Pasalar P; Panahi G; Meshkani R
    Cell Biochem Biophys; 2022 Sep; 80(3):537-545. PubMed ID: 35704155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention.
    Zhang Y; Takemori H; Wang C; Fu J; Xu M; Xiong L; Li N; Wen X
    Life Sci; 2017 Mar; 173():107-115. PubMed ID: 28174122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.
    Zhu X; Yan H; Xia M; Chang X; Xu X; Wang L; Sun X; Lu Y; Bian H; Li X; Gao X
    Lipids Health Dis; 2018 May; 17(1):114. PubMed ID: 29759071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of berberine on glucose metabolism in vitro.
    Yin J; Hu R; Chen M; Tang J; Li F; Yang Y; Chen J
    Metabolism; 2002 Nov; 51(11):1439-43. PubMed ID: 12404195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel berberine-metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats.
    Jia D; Li ZW; Zhou X; Gao Y; Feng Y; Ma M; Wu Z; Li W
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):533-544. PubMed ID: 30883863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP-kinase pathway is involved in tumor necrosis factor alpha-induced lipid accumulation in human hepatoma cells.
    Lv Q; Zhen Q; Liu L; Gao R; Yang S; Zhou H; Goswami R; Li Q
    Life Sci; 2015 Jun; 131():23-9. PubMed ID: 25817233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of baicalin with berberine for glucose uptake in 3T3-L1 adipocytes and HepG2 hepatocytes.
    Zhang CH; Yu RY; Liu YH; Tu XY; Tu J; Wang YS; Xu GL
    J Ethnopharmacol; 2014 Feb; 151(2):864-72. PubMed ID: 24361332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 9-O-benzoyl-substituted berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells.
    Cao S; Yu S; Cheng L; Yan J; Zhu Y; Deng Y; Qiu F; Kang N
    Environ Toxicol Pharmacol; 2018 Dec; 64():11-17. PubMed ID: 30268048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Compound of Mangiferin-Berberine Salt Has Potent Activities in Modulating Lipid and Glucose Metabolisms in HepG2 Cells.
    Wang C; Jiang JD; Wu W; Kong WJ
    Biomed Res Int; 2016; 2016():8753436. PubMed ID: 27123455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and structural optimization of 9-O-phenylsulfonyl-berberines as new lipid-lowering agents.
    Kong Y; Yi YJ; Liu XQ; Yu P; Zhao LG; Li DD
    Bioorg Chem; 2022 Apr; 121():105665. PubMed ID: 35152138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin reduces lipid accumulation in HepG2 cells via downregulation of miR-33b.
    Zare M; Panahi G; Koushki M; Mostafavi-Pour Z; Meshkani R
    Arch Physiol Biochem; 2022 Apr; 128(2):333-340. PubMed ID: 31686542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringaresinol-4-
    Wang S; Wu C; Li X; Zhou Y; Zhang Q; Ma F; Wei J; Zhang X; Guo P
    Acta Pharm Sin B; 2017 Jul; 7(4):453-460. PubMed ID: 28752030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of phytochemicals in combination with hypoglycemic drugs on glucose uptake in myotubes.
    Prabhakar PK; Doble M
    Phytomedicine; 2009 Dec; 16(12):1119-26. PubMed ID: 19660925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy.
    Zhu X; Yang J; Zhu W; Yin X; Yang B; Wei Y; Guo X
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from Salicornia herbacea attenuates high glucose-induced hepatic lipogenesis in human HepG2 cells through activation of the liver kinase B1 and silent information regulator T1/AMPK-dependent pathway.
    Pil Hwang Y; Gyun Kim H; Choi JH; Truong Do M; Tran TP; Chun HK; Chung YC; Jeong TC; Jeong HG
    Mol Nutr Food Res; 2013 Mar; 57(3):471-82. PubMed ID: 23349077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
    Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
    PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Separation of choline from Coptidis Rhizoma and impact on glucose metabolism of berberine in HepG2 cells].
    Chen H; Li X; Ye X; Jin Y; Huang J; Wu J
    Zhongguo Zhong Yao Za Zhi; 2012 Jun; 37(12):1771-4. PubMed ID: 22997822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation.
    Wang C; Li Y; Hao M; Li W
    Front Pharmacol; 2018; 9():345. PubMed ID: 29713279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.